PARIS--(BUSINESS WIRE)--Elixir Medical, a developer of breakthrough cardiovascular technologies, today announced that the large international randomized BIOADAPTOR RCT trial of the company’s DynamX ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback